TY - CHAP
T1 - Affinity-Based Microfluidics Combined with Atomic Force Microscopy for Isolation and Nanomechanical Characterization of Circulating Tumor Cells
AU - Deliorman, Muhammedin
AU - Glia, Ayoub
AU - Qasaimeh, Mohammad A.
N1 - Publisher Copyright:
© 2023, The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.
PY - 2023
Y1 - 2023
N2 - In this chapter, we present the materials and methods required to isolate and characterize circulating tumor cells (CTCs) from blood samples of cancer patients based on our newly developed microfluidic technologies. In particular, the devices presented herein are designed to be compatible with at\omic force microscopy (AFM) for post-capture nanomechanical investigation of CTCs. Microfluidics is well-established as a technology for isolating CTCs from the whole blood of cancer patients, and AFM is a gold standard for quantitative biophysical analysis of cells. However, CTCs are very scarce in nature, and those captured using standard closed-channel microfluidic chips are typically inaccessible for AFM procedures. As a result, their nanomechanical properties largely remain unexplored. Thus, given limitations associated with current microfluidic designs, significant efforts are put toward bringing innovative designs for real time characterization of CTCs. In light of this constant endeavor, the scope of this chapter is to compile our recent efforts on two microfluidic technologies, namely, the AFM-Chip and the HB-MFP, which proved to be efficient in isolating CTCs through antibody-antigen interactions, and their subsequent characterization using AFM.
AB - In this chapter, we present the materials and methods required to isolate and characterize circulating tumor cells (CTCs) from blood samples of cancer patients based on our newly developed microfluidic technologies. In particular, the devices presented herein are designed to be compatible with at\omic force microscopy (AFM) for post-capture nanomechanical investigation of CTCs. Microfluidics is well-established as a technology for isolating CTCs from the whole blood of cancer patients, and AFM is a gold standard for quantitative biophysical analysis of cells. However, CTCs are very scarce in nature, and those captured using standard closed-channel microfluidic chips are typically inaccessible for AFM procedures. As a result, their nanomechanical properties largely remain unexplored. Thus, given limitations associated with current microfluidic designs, significant efforts are put toward bringing innovative designs for real time characterization of CTCs. In light of this constant endeavor, the scope of this chapter is to compile our recent efforts on two microfluidic technologies, namely, the AFM-Chip and the HB-MFP, which proved to be efficient in isolating CTCs through antibody-antigen interactions, and their subsequent characterization using AFM.
KW - Antibody-antigen capture
KW - Atomic force microscopy
KW - Circulating tumor cells
KW - Herringbone micromixer
KW - Hydrodynamic flow confinement
KW - Microfluidic device
KW - Microfluidic probe
KW - Microfluidics
KW - Multiplexing
KW - Nanomechanical characterization
UR - http://www.scopus.com/inward/record.url?scp=85162172560&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85162172560&partnerID=8YFLogxK
U2 - 10.1007/978-1-0716-3271-0_4
DO - 10.1007/978-1-0716-3271-0_4
M3 - Chapter
C2 - 37300608
AN - SCOPUS:85162172560
T3 - Methods in Molecular Biology
SP - 41
EP - 66
BT - Methods in Molecular Biology
PB - Humana Press Inc.
ER -